Your browser is no longer supported. Please, upgrade your browser.
Settings
LIFE aTyr Pharma, Inc. daily Stock Chart
LIFE [NASD]
aTyr Pharma, Inc.
Index- P/E- EPS (ttm)-8.73 Insider Own0.10% Shs Outstand7.72M Perf Week-16.88%
Market Cap19.76M Forward P/E- EPS next Y-2.85 Insider Trans0.00% Shs Float7.60M Perf Month-39.76%
Income-24.00M PEG- EPS next Q-0.18 Inst Own24.20% Short Float0.62% Perf Quarter-40.33%
Sales0.30M P/S65.88 EPS this Y56.40% Inst Trans5.89% Short Ratio0.13 Perf Half Y-21.95%
Book/sh5.44 P/B0.47 EPS next Y4.50% ROA-52.90% Target Price10.33 Perf Year-64.92%
Cash/sh4.03 P/C0.64 EPS next 5Y13.00% ROE-87.70% 52W Range2.13 - 10.08 Perf YTD-38.61%
Dividend- P/FCF- EPS past 5Y14.50% ROI-76.80% 52W High-74.60% Beta2.23
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low20.19% ATR0.42
Employees44 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)36.57 Volatility14.03% 15.87%
OptionableNo Debt/Eq0.41 EPS Q/Q47.50% Profit Margin- Rel Volume0.15 Prev Close2.55
ShortableYes LT Debt/Eq0.00 EarningsMar 26 AMC Payout- Avg Volume371.99K Price2.56
Recom1.70 SMA20-11.77% SMA50-34.18% SMA200-36.00% Volume55,094 Change0.39%
Mar-04-20Initiated ROTH Capital Buy $15
Mar-02-20Initiated Oppenheimer Outperform $8
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Sep-07-17Initiated Piper Jaffray Overweight $7
Dec-13-16Downgrade JP Morgan Overweight → Neutral
Dec-16-15Initiated Citigroup Neutral
Jun-01-15Initiated JP Morgan Overweight $44
Jun-01-15Initiated Citigroup Buy $32
Mar-27-20 07:35AM  Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised) Zacks +5.19%
Mar-26-20 05:15PM  Atyr Pharma (LIFE) Reports Q4 Loss, Lags Revenue Estimates Zacks
04:01PM  aTyr Pharma Announces Fourth Quarter and Full Year 2019 Results and Provides Corporate Update GlobeNewswire
03:00PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-24-20 08:30AM  aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform GlobeNewswire
Mar-19-20 04:05PM  aTyr Pharma to Announce Fourth Quarter and Full Year End 2019 Financial Results on March 26th GlobeNewswire +11.71%
Mar-17-20 08:30AM  Leading Cancer Researcher Dr. Arthur M. Mercurio Joins aTyr as Scientific Advisor GlobeNewswire +9.68%
Mar-10-20 08:30AM  aTyr Pharma Announces Exercise and Closing of Over-Allotment Option in Public Offering GlobeNewswire
Mar-03-20 08:00AM  aTyr Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Feb-27-20 08:00AM  aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology GlobeNewswire
Feb-11-20 06:11PM  Andreas Halvorsen Plunges Into aTyr Pharma GuruFocus.com
Feb-06-20 09:00AM  aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering GlobeNewswire -11.53%
Feb-03-20 11:27AM  Andreas Halvorsen Trims Adaptive Biotechnologies Stake GuruFocus.com +5.92%
Jan-08-20 10:07AM  Biotech Stock Roundup: Updates From INCY & EXEL, APLS & LIFE Surge on Positive Data Zacks
Jan-07-20 09:26AM  Company News For Jan 7, 2020 Zacks
09:19AM  aTyr (LIFE) Surges on Collaboration Deal With Kyorin Pharma Zacks
Jan-06-20 08:00AM  aTyr Pharma Announces Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of ATYR1923 in Japan GlobeNewswire +43.43%
Dec-12-19 08:00AM  aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923 GlobeNewswire -10.23%
Dec-09-19 11:42AM  Edited Transcript of LIFE earnings conference call or presentation 14-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-14-19 04:01PM  aTyr Pharma Announces Third Quarter 2019 Results and Provides Corporate Update GlobeNewswire -6.20%
Nov-13-19 08:00AM  aTyr Pharma to Present at the Stifel Healthcare Conference 2019 GlobeNewswire
Nov-07-19 08:00AM  aTyr Pharma to Announce Third Quarter Results on November 14th GlobeNewswire +9.12%
Oct-22-19 08:00AM  aTyr Pharma Announces Research Collaboration with Boston Childrens Hospital GlobeNewswire
Sep-19-19 06:53PM  Edited Transcript of LIFE earnings conference call or presentation 14-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Sep-18-19 08:00AM  aTyr Pharma to Participate in September Conferences GlobeNewswire
Sep-12-19 03:05AM  First Day of Dealings for UK Cannabis Investment Company GlobeNewswire +9.55%
Sep-04-19 08:00AM  aTyr Pharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-14-19 08:00AM  aTyr Pharma Announces Second Quarter 2019 Results and Provides Corporate Update GlobeNewswire -5.72%
Aug-07-19 08:00AM  aTyr Pharma to Announce Second Quarter 2019 Results on August 14th GlobeNewswire
Aug-06-19 08:00AM  Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor GlobeNewswire
Jul-10-19 08:00AM  aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape GlobeNewswire
Jul-01-19 08:00AM  aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members GlobeNewswire +6.48%
Jun-28-19 04:05PM  aTyr Pharma Announces Reverse Stock Split to Regain NASDAQ Compliance GlobeNewswire
May-27-19 03:41PM  Edited Transcript of LIFE earnings conference call or presentation 13-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-13-19 04:27PM  Atyr Pharma: 1Q Earnings Snapshot Associated Press
04:05PM  aTyr Pharma Announces First Quarter 2019 Results and Provides Corporate Update GlobeNewswire
May-06-19 04:58PM  aTyr Pharma to Announce First Quarter 2019 Results on May 13th GlobeNewswire
Apr-16-19 08:00AM  aTyr Pharma to Host Inaugural Summit Meeting on Neuropilin-2 (NRP-2) Biology GlobeNewswire
Apr-11-19 08:00AM  aTyr Pharma Announces $5 Million Registered Direct Offering led by The Federated Kaufmann Small Cap Fund GlobeNewswire
Apr-10-19 11:05AM  Edited Transcript of LIFE earnings conference call or presentation 25-Mar-19 9:00pm GMT Thomson Reuters StreetEvents
Apr-08-19 04:00PM  aTyr Pharma to Present Poster at the American Thoracic Society 2019 International Conference GlobeNewswire +7.72%
Mar-28-19 09:00AM  Atyr Pharma (LIFE) Upgraded to Buy: Here's Why Zacks
Mar-25-19 04:16PM  Atyr Pharma: 4Q Earnings Snapshot Associated Press -9.51%
04:00PM  aTyr Pharma Announces Fourth Quarter and Full Year 2018 Results and Provides Corporate Update GlobeNewswire
03:00PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-21-19 08:00AM  aTyr Pharma Announces Poster Presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire +14.04%
Mar-18-19 04:46PM  aTyr Pharma to Announce Fourth Quarter and Full Year 2018 Financial Results on March 25th GlobeNewswire
Mar-11-19 08:00AM  aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring GlobeNewswire
Mar-04-19 05:36PM  aTyr Pharma Announces Participation at March Investor Conferences GlobeNewswire -5.32%
Feb-27-19 04:00PM  aTyr Pharma Presents Compelling Preclinical Data Highlighting Potential of ATYR1923 to Regulate Myeloid Cell Biology During Lung Inflammation GlobeNewswire
Feb-21-19 06:20PM  Evolve Announces February 2019 Distributions for Evolve ETFs CNW Group
Feb-05-19 04:05PM  aTyr Pharma to Present at the BIO CEO & Investor Conference GlobeNewswire
Jan-30-19 04:00PM  aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study GlobeNewswire
Jan-16-19 04:00PM  Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease GlobeNewswire
10:16AM  Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger Zacks
Jan-15-19 06:23AM  What Bargain Hunting? Tap 5 Stocks With Rising P/E Zacks +8.24%
Jan-02-19 07:37PM  aTyr Pharma Announces Participation at Upcoming San Francisco Investor Events GlobeNewswire +6.92%
Dec-21-18 01:51PM  Need To Know: aTyr Pharma, Inc. (NASDAQ:LIFE) Insiders Have Been Buying Shares Simply Wall St. -6.98%
Dec-04-18 08:00AM  aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR) GlobeNewswire -5.36%
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks
Nov-28-18 08:16PM  aTyr Pharma to Present at the BMO 2018 Prescriptions for Success Healthcare Conference GlobeNewswire
07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-21-18 08:50AM  Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-13-18 04:21PM  Atyr Pharma: 3Q Earnings Snapshot Associated Press -9.59%
04:05PM  aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update GlobeNewswire
Nov-08-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 13, 2018 GlobeNewswire +6.21%
Oct-17-18 08:00AM  aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting GlobeNewswire
Oct-15-18 04:30PM  aTyr Pharma Announces Leadership Transition GlobeNewswire
Sep-27-18 04:05PM  aTyr Pharma Announces Pulmonary Sarcoidosis as Disease Indication for Phase 1b/2a Clinical Study and Educational Webinar GlobeNewswire
Sep-20-18 04:38PM  aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference GlobeNewswire
Aug-30-18 05:51PM  Edited Transcript of LIFE earnings conference call or presentation 14-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
08:00AM  aTyr Pharma to Present at the Baird 2018 Global Healthcare Conference GlobeNewswire
Aug-14-18 05:03PM  Atyr Pharma: 2Q Earnings Snapshot Associated Press
04:05PM  aTyr Pharma Announces Second Quarter 2018 Operating Results and Provides Corporate Update GlobeNewswire
03:00PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-08-18 04:05PM  aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018 GlobeNewswire
Jul-31-18 08:00AM  aTyr Pharma Appoints Jill Broadfoot as Chief Financial Officer GlobeNewswire
Jul-26-18 08:00AM  aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference GlobeNewswire
Jun-26-18 08:00AM  aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate GlobeNewswire -8.18%
Jun-08-18 01:46PM  Edited Transcript of LIFE earnings conference call or presentation 19-Mar-18 9:00pm GMT Thomson Reuters StreetEvents +14.44%
May-31-18 08:00AM  aTyr Pharma to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-17-18 07:30AM  aTyr Pharma Presents Poster on Preclinical Data from ATYR1923 Program at American Thoracic Society 2018 International Conference GlobeNewswire +14.71%
May-15-18 08:06AM  Edited Transcript of LIFE earnings conference call or presentation 14-May-18 12:00pm GMT Thomson Reuters StreetEvents -12.90%
May-14-18 06:49AM  Atyr Pharma: 1Q Earnings Snapshot Associated Press -32.61%
06:45AM  aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring GlobeNewswire
06:00AM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
May-08-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018 GlobeNewswire
May-02-18 08:00AM  aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting GlobeNewswire
Mar-26-18 08:14AM  aTyr Pharma, Inc. (LIFE) Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-19-18 04:37PM  Atyr Pharma reports 4Q loss Associated Press
04:05PM  aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update GlobeNewswire
12:30PM  aTyr Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 08:00AM  aTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018 GlobeNewswire
Mar-01-18 08:00AM  aTyr Pharma to Present at Two Upcoming Investor Conferences in March GlobeNewswire
Dec-21-17 08:00AM  aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium GlobeNewswire
Dec-07-17 08:00AM  aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-27-17 08:00AM  aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923) GlobeNewswire
Nov-21-17 08:00AM  aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference GlobeNewswire
Nov-16-17 05:14AM  Atyr Pharma reports 3Q loss Associated Press
Nov-14-17 04:05PM  aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update GlobeNewswire
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923 candidate, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial for regulating immune engagement in interstitial lung diseases. The company has a collaboration with the University of Nebraska Medical Center for the development of NRP2 biology; research collaboration and option agreement with CSL Behring for the development of product candidates derived from up to four tRNA synthetases; and research collaboration with Boston Children's Hospital. It also has license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of ATYR1923 for ILDs in Japan. The company was founded in 2005 and is headquartered in San Diego, California.